...
首页> 外文期刊>Danishgah-i Ulum-i Pizishki va Khadamat-i Bihdashti-Darmani Shahid Sadugi Yazd. Majallah >Evaluation of Prognostic and Predictive Factors in Pediatric Acute Lymphoblatic Leukemia Patients Admitted to Shahid Sadoughi Hospital
【24h】

Evaluation of Prognostic and Predictive Factors in Pediatric Acute Lymphoblatic Leukemia Patients Admitted to Shahid Sadoughi Hospital

机译:Shahid Sadoughi医院收治的小儿急性淋巴细胞白血病患者预后和预测因素的评估

获取原文
           

摘要

Introduction: The most common neoplasm in childhood is acute leukemia and about 30% of all cancers are luekemias. Treatment based on prognostic factors has improved survival rate during the last two decades. As prognostic factors differ in different populations, this study was done to evaluate the factors in Yazd. Methods: This descriptive observational study was done as a case series study. The population under study included 56 children in the age range of 0-14 years and all of them were admitted to Shahid Sadoghi Hospital of Yazd. To obtain predicting clinical (age, gender.hepatomegaly…) and laboratory (CBC, LDH, Flow cytometry…) factors in outcome of disease (Relapse and death), statistic technique of Cox Proportional Hazard Ratio and chi-square tests were used. All prognostic factors were with univariate and multivariate analyses. Results: Only WBC count 50000 in both univariate and multivariate analyses was predictive factor for death. (p.v:0.008, HR: 21.77, 95% CI=2.33 -75.11). Conclusion: Patients with WBC count 50000 were 22 times more at risk of death than those with lesser counts. Therefore, these patients should be considered as a high risk group.
机译:简介:儿童期最常见的肿瘤是急性白血病,所有癌症中约30%是白血病。在过去的二十年中,基于预后因素的治疗提高了生存率。由于不同人群的预后因素不同,本研究旨在评估亚兹德的因素。方法:该描述性观察性研究是作为病例系列研究进行的。受研究的人群中包括56名0-14岁的儿童,所有儿童均被送往Yazd的Shahid Sadoghi医院。为了获得预测疾病(复发和死亡)结果的临床(年龄,性别,肝肿大...)和实验室(CBC,LDH,流式细胞术...)因素的预测,使用了Cox比例风险比的统计技术和卡方检验。所有预后因素均采用单因素和多因素分析。结果:单因素和多因素分析中只有WBC计数为50000是死亡的预测因素。 (p.v:0.008,HR:21.77,95%CI = 2.33 -75.11)。结论:WBC计数为50000的患者死亡风险比计数较少的患者高22倍。因此,这些患者应被视为高危人群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号